Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eyecyte-RPE in Geographic Atrophy Secondary to Dry AMD
NCT06394232Phase 2Recruiting
- Sponsor
- Eyestem Research
- Start
- Jun 2024
- Primary completion
- Apr 2025
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of Eyecyte-RPE in geographic atrophy (GA), sponsored by Eyestem Research. Started Jun 2024; status: recruiting.
02
Drugs
Eyecyte-RPE
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT06394232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06394232.